This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.
Please go to www.ahrq.gov for current information.
Table 1.47a
Percent of heart failure patients who received recommended hospital care,a Medicare beneficiaries, United States, 2002 and 2004
| |
|
2004 |
2002 |
| Population group |
Percent |
Standard error |
Percent |
Standard error |
| Total |
77.7 |
0.2 |
73.4 |
0.2 |
| Gender |
Male |
78.4 |
0.3 |
DNA |
DNA |
| Female |
77.1 |
0.3 |
DNA |
DNA |
| Race |
White |
77.9 |
0.3 |
73.4 |
0.3 |
| Black |
78.1 |
0.6 |
74.9 |
0.7 |
| Hispanic |
73.5 |
1.5 |
68.6 |
1.6 |
| Native American |
72.3 |
2.3 |
68.9 |
2.3 |
| Asian |
78.6 |
2.1 |
76.3 |
2.3 |
| Age |
Under 65 |
76.0 |
0.7 |
DNA |
DNA |
| 65-74 |
80.0 |
0.4 |
DNA |
DNA |
| 75-84 |
78.3 |
0.4 |
DNA |
DNA |
| 85 and over |
75.3 |
0.5 |
DNA |
DNA |
a Recommended hospital care for heart failure includes receiving evaluation of left ventricular ejection fraction, and prescription of an angiotensin converting enzyme (ACE) inhibitor at discharge for patients with left ventricular systolic dysfunction.
DNA - Data have not been analyzed.
Source: Centers for Medicare & Medicaid Services, Medicare Quality Improvement Organization Program.
Return to Contents